with exercise, through measurement of body weight, 24-h urinary sodium and potassium, and a questionnaire. Medication, if any, was withdrawn at least 6 weeks before the study. All of the participating patients signed a consent form after being well informed regarding the nature and purpose of the study. This study was approved by the Ethics Committee of Fukuoka University.
This study is presented as 2 separate studies (A and B) to simplify interpretation.
Study A This part of the protocol was performed to examine the significance of humoral factors in the depressor responses of essential hypertensives to mild exercise therapy by comparing these variables among patients with different responses of BP to mild hypotensive exercise therapy. It included 67 patients in whom BP either responded well (responders) or did not respond (non-responders) to mild exercise therapy. Responders were defined as those patients whose MBP consistently decreased more than the median reduction in MBP for all of the patients at 2, 3, 4, and 10 weeks (n=46; mean age: 56.7±6.3 years; F/M: 38/8), whereas non-responders were defined as those whose MBP consistently decreased less than the median reduction in MBP for all of the patients at 2, 3, 4, and 10 weeks (n=21; mean age: 54.9±8.7 years; F/M: 13/8).
Patients who did not complete 10 weeks of mild exercise therapy or who had no consistent changes in MBP or a median reduction in BP during the study were excluded from Study A.
Study B This part of the protocol was performed to examine the significance of baseline BP and humoral variables as factors for predicting the depressor response of patients with essential hypertension to mild exercise therapy. All of the patients (n=122) were divided into good responders and poor responders according to their BP response to mild exercise therapy. Good responders were defined as patients who showed a fall in MBP of more than 10 mmHg or whose SBP and DBP were below 140 mmHg and 90 mmHg at 4 weeks of exercise therapy (n=41; mean age: 56.9±6.4 years; F/M: 34/7), and poor responders were defined as patients who showed a fall in MBP of 10 mmHg or less and whose SBP and DBP were equal to or greater than 140 mmHg and 90 mmHg (n=81; mean age: 53.2±7.2 years; F/M: 63/18).
Method of Exercise Therapy
All the patients performed bicycle ergometer exercise 3 times a week for 10 weeks in an air-conditioned room under the same temperature (20-22°C) and humidity (40-60%) conditions over the course of 1 year. The intensity of the exercise was the workload at the lactate threshold, which occurs at approximately 50% of maximum oxygen uptake. 8, 9 This work load reflects mild aerobic exercise and was pre-determined for each patient before exercise by a test using multistage graded submaximal exercise. 7 Each training section began with a 5-10-min warming-up period of light calisthenics and stretching, followed by 60 min of exercise on the bicycle ergometer with a weight and rhythm box (Cyclotek, Monark-Crescent A.B., Varberg, Sweden) at the lactate threshold intensity for each subject, and ended with a 5-min cooling-down period. The exercise was supervised by a physical education instructor. Watching television or listening to the radio was allowed during the exercise.
Measurement of BP and Humoral Factors
BP was measured indirectly using a mercury sphygmomanometer before and after 1, 2, 3, 4, and 10 weeks of exercise therapy. BP was measured twice in the left arm with the patient sitting in a chair, after more than 5 min of rest, and the average was taken. BP was measured once weekly during the observation period. The average BP value of the last 3 visits was used as a baseline value for each patient. BPs were measured at each visit more than 48 h after the last exercise session, and therefore were measured 3 times a week. The average BP of the last 3 visits in each period was taken as the value at each time point during the study period (ie, at 1, 2, 3, 4, and 10 weeks).
Before and at 4 and 10 weeks of exercise therapy, plasma volume was measured at rest 48-72 h after the last exercise and after an 8-h fast from solid food (without refraining from drinking water) by using 131 I-labeled human serum albumin, according to the method of Crispell et al 10 and is presented as an index divided by body surface area.
Before and after 1, 2, 3, 4, and 10 weeks of exercise therapy, 24-h urine and 12-h fasting blood samples were collected. Blood samples were drawn from the antecubital vein into vacuum tubes after a 15-min rest period (sitting position), immediately placed on ice, and centrifuged at 1,800 G at 4°C. The plasma was stored at -20°C until assayed. The urine samples were collected using a simple portable device according to the method of Tochikubo et al. 11 Plasma renin activity (PRA) was measured by radioimmunoassay, 12 and the plasma free epinephrine and norepinephrine concentrations were measured by the trihydroxyindole method after extraction by high-performance liquid chromatography. 13 Urine sodium and potassium concentrations were determined by the flame photometric method (Flame Photometer 755; Hitachi, Tokyo, Japan).
Statistical Analysis
All of the statistical analyses were performed using the Statistical Analysis System (Ver. 6.12, SAS Institute Inc, Cary, NC, USA). Within-group changes in BP during the period of exercise therapy were examined by a multivariate repeated measures analysis of variance using the GLM (general linear models) procedure. 14 Within-group changes in variables other than BP during the study period were examined by a one-way analysis of variance for unbalanced design using the GLM procedure because of some missing values, and the data were presented as leastsquares means (LSmean) ± standard error (SE). The differences between means at each time point during the study period and the baseline means were tested by the multiple comparison method of Dunnett. 14 Between-group differences in BP and other variables at each time point in the study period were compared by an analysis of variance using the GLM procedure, 14 and data were presented as LSmean ± SE if adjusted for age and sex and as mean ± standard deviation if not adjusted for other variables. Correlations between changes in BP and changes in other variables were examined by the Spearman correlation using the CORR (correlation) procedure. 15 Associations between the depressor response [which was given a value of 1 for good responders and 0 for poor responders] and baseline values of MBP and humoral factors were examined by a linear logistic regression analysis using the LOGISTIC procedure. A discriminant analysis was per-formed to examine the ability of baseline values of MBP and humoral factors to classify patients as good and poor responders using the DISCRIM (discriminant analysis) procedure. 16 Significant variables for discriminant analysis were selected using the STEPDISC (stepwise discriminant analysis) procedure. 14 The variance that baseline values of MBP and humoral factors contributed to the depressor effect of exercise therapy (good and poor responses) was evaluated by a variance component analysis using the VARCOMP (variance component) procedure. 14 Categorized variables were used in the logistic regression analysis, the variance component analysis, and the discriminant analysis, and categorization was performed using the UNIVARIATE procedure, 15 which gives medians and 25% and 75% quartile values of each baseline variable.
Results

Efficacy of Exercise Therapy
The changes in SBP, DBP, and MBP for all of the patients (n=122) during the period of exercise therapy are shown in Fig 1A- C, respectively. All measures of BP significantly decreased after 1 week of exercise and continue to decrease (almost linearly) until 4 weeks. From 4 weeks to 10 weeks, BP was stable, indicating that mild exercise at a workload equivalent to the blood lactate threshold is effective in essential hypertensives. The heart rate in this group of patients decreased slightly at 4 and 10 weeks, but not significant (baseline heart rate: 77.1±9.3 beats/min; 4 weeks: 74.4±9.1 beats/min; 10 weeks: 74.5±9.4 beats/min).
Study A
In Study A, we examined whether or not changes in plasma volume and humoral factors were significantly associated with the depressor effects of exercise therapy by comparing the time courses of BP, plasma volume and humoral factors during the 10-week period of exercise therapy between responders (n=46) and non-responders (n=21). Table 1 shows that the characteristics of the 2 selected groups of patients were not significantly different. Baseline plasma volume and humoral factors were also not significantly different between responders and non-responders. Fig 2 shows the changes in SBP, DBP, plasma aldosterone concentration (PAC), plasma renin activity (PRA), plasma free epinephrine concentration (PFE), plasma free norepinephrine concentrations (PFNE), plasma volume and the ratio of the urine sodium and potassium concentrations (UNa:K) during the study period for patients who did and did not respond to mild hypotensive exercise therapy, after adjusting for age and sex. The adjusted data are presented as LSmeans ± standard error. As shown in Fig 2, no significant differences in the baseline (0 weeks) values of SBP, DBP, plasma volume, and humoral factors were observed between the 2 groups of patients after controlling for age and sex. During the period of exercise therapy, withingroup changes in SBP and DBP were significant in responders, but not in non-responders, as assessed by a multivariate repeated measures analysis of variance. Responders showed a significant decrease in SBP beginning at 1 week and a significant decrease in DBP beginning at 2 weeks (indicated by * in Fig 1) . Within-group changes in plasma volume and humoral factors for responders or non-responders were not significant, as assessed by an analysis of variance. The differences in SBP and DBP between responders and non-responders were significant at each time point in the period of the exercise therapy (2, 3, 4, and 10 weeks, respectively, indicated by †). Between-group differences in plasma volume and humoral factors were not significant during the 10-week period of exercise therapy, except that at 10 weeks the ratio of urine sodium to potassium was significantly lower in responders than in non-responders. These results indicate that plasma volume and humoral factors did not change significantly during the entire study period and were not significantly different between responders and non-responders, suggesting that the depressor responses of essential hypertensives to exercise therapy may not be attributable to plasma volume or humoral factors.
Study B
In Study B, we examined the significance of baseline (0 weeks) values of MBP, plasma volume, and humoral factors in predicting the depressor responses of essential hypertensives to exercise therapy. Because there was no further reduction in MBP in any of the patients from 4 weeks to 10 weeks, as shown in Fig 1, we used the data for BP at 4 weeks to classify the patients as good responders and poor responders to mild hypotensive exercise therapy, to simplify data collecting (some patients completed a 4-week exercise program, but dropped out of the study before 10 weeks). Table 2 shows the characteristics and age-and sex-adjusted baseline values of MBP, plasma volume, and humoral factors in the good responders and poor responders. Good responders were older and had a lower body mass index than poor responders. The age-and sex-adjusted baseline values of SBP (147±2 mmHg vs 155±2 mmHg, p<0.05) and MBP (113±1 mmHg vs 116±1 mmHg, p<0.05) in good responders were significantly lower than those in poor responders. No significant differences were observed for age-and sex-adjusted baseline values of DBP, plasma volume, and humoral factors between good responders and poor responders. For the logistic function analysis, discriminant analysis, and variance component analysis, the baseline MBP, plasma volume, and humoral factors were transformed into categorical variables according to the 25% quartile, median, and 75% quartile values of the respective variable in all of the patients.
We performed a stepwise multiple logistic analysis that included baseline MBP, plasma volume, and humoral factors (PRA, PAC, PFE, PFNE, and UNa:K) in the model as independent variables. Only the baseline MBP entered and stayed in the model at a significance level of 0.05. The results are shown in Table 3 . Only MBP was significantly (p=0.002) associated with the depressor response; other variables were not significant because they did not enter the model. The odds ratio for MBP with 4 levels was 1.842, indicating that increasing values of MBP were associated with an increased relative risk for having a poor depressor response. Table 3 also shows that the results of a logistic regression analysis, which used dummy variables of MBP, indicated that, relative to patients with a MBP lower than the 25% quartile value, patients with a MBP between the 25% quartile and median values had a 2.93-fold greater risk for a poor depressor response. Patients with a MBP between the median and 75% quartile values and patients with a MBP higher than the 75% quartile value had a 6.67-and 5.49-fold greater risk for a poor depressor response, respectively. When MBP was categorized into 2 levels, the results of a logistic regression analysis showed that patients with a MBP higher than the median MBP had a 3.30-fold higher risk for a poor depressor response, relative to patients with a MBP lower than or equal to the median MBP (Table 3) .
We also performed a discriminant analysis to examine the ability of baseline MBP, plasma volume, and humoral factors to classify patients as good or poor responders. The discrimination model was constructed by stepwise selec- Table 4 . The variance that is attributable to the baseline MBP (with a variance component of 0.019) is considerably greater than that attributable to other variables (0.000 for each variable). However, because the MBP variance is considerably smaller than the error variance, the MBP does not play an important role in the overall variability of the responses to exercise therapy. Baseline MBP accounted for only 11.2% of the total variance, and error accounted for 79.7% (Table 4) . These results confirmed those obtained by the logistic regression analysis and the discriminant analysis.
Discussion
Exercise as a non-pharmacological therapy has been shown to be effective in lowering BP in essential hypertensives. [1] [2] [3] Our study confirmed the antihypertensive effect of exercise therapy by examining the time course of BP in patients (n=122) with essential hypertension during a 10-week period of mild (lactate threshold intensity) exercise. A workload at the blood lactate threshold was used in our study because optimum results can be achieved for exercise therapy at this intensity. 7 However, different responses to mild exercise therapy have been observed among essential hypertensive individuals. 1, 6 Our finding in study A (and Fig 1) that responders had significantly greater reductions in systolic and diastolic BP during the 10-week period of exercise therapy than nonresponders (Fig 2) supports this notion. We previously studied the mechanism by which mild exercise decreases BP in patients with essential hypertension and found that reduced plasma volume and plasma norepinephrine concentrations were associated with the antihypertensive effects of mild exercise on essential hypertension. 17 The present study investigated the contribution of hemodynamic and humoral factors to the variation in depressor responses to exercise therapy and the significance of the baseline values of these factors in predicting the depressor response of essential hypertensives to mild exercise therapy. Our result in study A that plasma volume and humoral factors were not significantly different between responders and non-responders to mild hypertensive exercise therapy (Fig 2) suggests that although volume-depleting effects contribute to the depressor effects of mild exercise in responders (n=12), 17 variations in the depressor response to mild exercise in patients with hypertension may not be attributable to plasma volume or humoral factors. The results of Study A agreed with our previous finding that demonstrated no differences, between responders (n=12, 10 mmHg or greater reduction in MBP at 10 weeks) and non-responders (n=9, less than 10 mmHg reduction in MBP at 10 weeks), in some humoral factors at 10 weeks of exercise. 6 We 6 previously reported significant decreases in plasma volume and decreases in plasma norepinephrine during the period of exercise therapy in the responders (n=12), however, in this whole summarized report we did not find any significant changes in plasma volume or plasma norepinephrine in responders (n=46). The data included and the methods used for statistical analysis may have caused this discrepancy. In our previous study, changes in plasma volume and humoral factors before and after 10 weeks of mild exercise were examined by a paired t test. However, in the present study we also included data at 1, 2, and 4 weeks of mild exercise and examined the patterns of change in plasma volume and humoral factors by a multivariate repeated measures analysis of variance. Therefore, in the present study significant changes were detected only in those variables that changed in the same direction at 1, 2, 4, and 10 weeks of mild exercise, such as SBP and DBP in the responders (Fig 2) . Our present results do not necessarily contradict our previous findings, but rather reflect relatively large variations in plasma volume and humoral factors during the 10 weeks of mild hypotensive exercise therapy. Although humoral factors did not determine the response of essential hypertensives to exercise therapy, whether or not they play a significant role in predicting the depressor response is still of considerable interest. Arakawa 1 indicated that effective depressor responses to exercise therapy could be expected in hypertensive patients with a lower baseline BP and/or a higher baseline serum sodium: potassium ratio. In study B, we divided all of the patients (n= 122) in the study into good responders and poor responders according their depressor responses at 4 weeks, and studied the significance of the baseline MBP, plasma volume, and humoral factors in predicting the depressor response of essential hypertensives to mild exercise therapy by performing a multiple logistic analysis, a discriminant analysis, and a variance component analysis. Our findings that baseline systolic and MBP were significantly different between good and poor responders confirm that of Arakawa. 1 However, it is not clear whether baseline MBP predicts the depressor response to mild exercise therapy independent of plasma volume and humoral factors. Our results of a stepwise multiple logistic analysis show that baseline MBP was significantly associated with the depressor response independent of baseline plasma volume or humoral factors. The results of a logistic regression analysis showed that patients with high MBP had a 3.30-fold higher possibility of having a poor depressor response than patients with low MBP (Table 3) , and the results of a stepwise discriminant analysis also confirmed that baseline MBP was significant in classifying patients as good and poor responders.
No previous study has investigated the accuracy of baseline BP in predicting the depressor response of mild exercise therapy. This study is the first to show that the sensitivity and specificity of a discrimination model which used the baseline MBP to discriminate good and poor responders were low, at 68.3% and 60.5%, respectively. This can be explained by the results of a component analysis which showed that although the variance component of the baseline MBP was much larger than those of the baseline plasma volume and humoral factors (Table 4) , it accounted for only 11.2% of the total variance of the depressor response, which indicates that the baseline MBP plays only a minor role compared to other unknown errors. The finding that a large portion of the total variance of the depressor response could be accounted for by error variance support the notion that multiple factors (environmental and/or genetic) are involved in the pathogenesis of hypertension. Therefore, we investigated in our later study the association between angiotensin-converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphism, which accounts for about 50% of the variance of blood ACE activities, and the depressor response to mild exercise therapy, and found that the DD genotype was associated with a worse depressor response than the II genotype. 18 Although the mechanism for this association is not fully understood, in a recent study we found that the ACE I allele was associated with an increased percentage of type I skeletal muscle in a group of young healthy subjects. 19 However, whether or not there is any significant role of an increased percentage of type I skeletal muscle on hypotensive effects of exercise is not examined in the present study and needs futher investigation.
In conclusion, in this summarized report, the variance in the depressor response of essential hypertensives to mild exercise therapy was not attributable to plasma volume or humoral factors, and baseline MBP only partly predicted the depressor response of essential hypertensives to mild exercise therapy, and this constitutes important support for a study to search for a link between genetic factors and the variation in the depressor response to mild exercise therapy.
